Results 201 to 210 of about 3,166,261 (352)

Expression patterns of MRP2 in circulating tumor cells of breast cancer: a single-institution study. [PDF]

Front Oncol
Guan J, Li F, Zhou W.
europepmc   +1 more source

Some Characteristics of DNA Synthesis and the Mitotic Cycle in Ehrlich Ascites Tumor Cells [PDF]

, 1960
Joshua L. Edwards, Arthur L. Koch, Pauline Youcis, Herbert L. Freese, Melville B. Laite, J. Thomas Donalson   +5 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Cellular Mechanisms of Photobiomodulation in Relation to HeLa Kyoto Tumor Cells Exposed to Ionizing Radiation. [PDF]

Int J Mol Sci
Maslennikova AV, Belotelov AO, Cherkasova EI, Yusupov VI, Kononova UA, Shilyagina NY, Skamnitsky DV.   +6 more
europepmc   +1 more source

Ultrastructure of myoepithelial cells in human mammary gland tumors [PDF]

, 1968
Tariq M. Murad, E. Von Haam
openalex   +1 more source

Multi‐omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma

Molecular Oncology, EarlyView.
Using multi‐omic characterization, we aimed to identify key regulators specific to squamous cell lung carcinoma (SqCC). SqCC‐specific differentially expressed genes were integrated with metabolics data. High expression of the creatine transporter SLC6A8, along with elevated creatine levels, appeared to be a distinct metabolic feature of SqCC.
Johan Staaf, Daniel Ehinger, Hans Brunnström, Mats Jönsson, Frida Rosengren, Marija Kotevska, Anna Karlsson, Mattias Aine, Christian Frezza, Maria Planck, Elsa Arbajian   +10 more
wiley   +1 more source

Cooperation between ZEB2 and SP1 upregulates PD‑L1 and CCL2 to promote the immunosuppressive activity of tumor cells. [PDF]

Int J Oncol
Ko D, Lee Y, Yoon J, Choi EK, Jang D, Kim S.   +5 more
europepmc   +1 more source

INDUCTION OF MYELOMA PROTEIN SYNTHESIS IN EHRLICH ASCITES TUMOR CELLS BY THE ADDITION OF A PLASMA CELL TUMOR (X5563) RNA

, 1964
Kazuo Moriwaki
openalex   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Hydrophobin-Coated Echogenic Microbubbles for Molecular Targeting of Tumor Cells. [PDF]

Adv Sci (Weinh)
Al-Terke HH, Beaune G, Junaid M, Seitsonen J, Paananen A, Metrangolo P, Timonen JVI, Joensuu J, Ras RHA.   +8 more
europepmc   +1 more source